Old Dominion Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4M Hold
10,737
0.86% 38
2021
Q2
$4.1M Buy
10,737
+175
+2% +$66.9K 0.88% 39
2021
Q1
$3.79M Buy
10,562
+118
+1% +$37.9K 0.88% 38
2020
Q4
$3.35M Sell
10,444
-36
-0.3% -$11K 0.83% 40
2020
Q3
$2.81M Buy
10,480
+44
+0.4% +$11.8K 0.79% 41
2020
Q2
$2.74M Buy
10,436
+7
+0.1% +$1.87K 0.85% 38
2020
Q1
$2.37M Buy
10,429
+143
+1% +$39K 0.98% 36
2019
Q4
$3.11M Buy
10,286
+355
+4% +$97.7K 1.01% 35
2019
Q3
$2.38M Buy
9,931
+175
+2% +$47.9K 0.8% 41
2019
Q2
$2.75M Hold
9,756
0.95% 37
2019
Q1
$2.55M Buy
9,756
+825
+9% +$239K 0.87% 40
2018
Q4
$2.35M Buy
+8,931
New +$2.46M 0.85% 39

Other funds holding ELV

Old Dominion Capital Management's ELV Position: Q3 2021 in Review

Old Dominion Capital Management held its Elevance Health (ELV) position steady in Q3 2021 at 10,737 shares worth $4M. The position accounts for 0.86% of the portfolio, ranked #38.

Old Dominion Capital Management first reported a position in ELV in Q4 2018 and has held it in 12 quarters since. The position peaked at $4.1M in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Old Dominion Capital Management held 10,737 shares of Elevance Health worth $4M as of Q3 2021.
  • Old Dominion Capital Management left its Elevance Health share count unchanged in Q3 2021.
  • Elevance Health made up 0.86% of Old Dominion Capital Management's portfolio in Q3 2021, its #38 holding.
  • Old Dominion Capital Management first reported a position in Elevance Health in Q4 2018 and has held it in 12 quarters since.
  • Old Dominion Capital Management's Elevance Health position peaked at $4.1M in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.